3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
3
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large-Cell, Anaplastic
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
pembrolizumab
14
Cisplatin
7
Cetuximab
6
Carboplatin
4
dostarlimab
3
Surveys and Questionnaires
3
fludarabine
2
abemaciclib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Interviews as Topic
2
Fulvestrant
2
Docetaxel
2
Cyclophosphamide
2
Blood Specimen Collection
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
trastuzumab deruxtecan
1
tislelizumab
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nimotuzumab
1
monalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
duvelisib
×
30 days
×
Clear all
No trials found.